The between team

Executives at the Department of Health and Human Services have named a few acting agency heads as the US government prepares to transition into a new administration under President-Elect Barack Obama. There are no real surprises, with deputies or second-in-commands taking over next week and serving at top spots until successors are named by incoming HHS head linkurl:Tom Daschle;http://www.the-scientist.com/blog/display/55206/ or directly by Obama.

By | January 12, 2009

Executives at the Department of Health and Human Services have named a few acting agency heads as the US government prepares to transition into a new administration under President-Elect Barack Obama. There are no real surprises, with deputies or second-in-commands taking over next week and serving at top spots until successors are named by incoming HHS head linkurl:Tom Daschle;http://www.the-scientist.com/blog/display/55206/ or directly by Obama. Cancer biologist linkurl:Frank Torti,;http://www1.wfubmc.edu/canbio/Faculty/Torti+F.htm who spoke with __The Scientist__ last year when he was named the Food and Drug Administration's first ever Chief Scientist, will serve as FDA head starting on Inauguration Day, January 20th. You can hear a snippet of the conversation I had with Torti linkurl:here.;http://images.the-scientist.com/supplementary/audio/torti_cut.wav Other temporary assignments include linkurl:Raynard Kington;http://www.nih.gov/about/director/index.htm staying on as acting director of the National Institutes of Health, and Centers for Disease Control & Prevention chief operating officer linkurl:William Gimson;http://www.cdc.gov/about/leadership/leaders/gimson.htm taking over when current director linkurl:Julie Gerberding;http://www.cdc.gov/about/leadership/director.htm leaves the post. The Washington, D.C. rumor mill has suggested that genomicist linkurl:Francis Collins;http://www.the-scientist.com/community/posts/list/333.page may be next in line to serve as NIH director, and that Clinton-era FDA commissioner linkurl:Jane Henney;http://www.fda.gov/oc/commissioners/henney.html could return to her old post. Other names bandied about as potential FDA commissioners include another former comish, linkurl:David Kessler,;http://www.fda.gov/oc/commissioners/kessler.html and Cleveland Clinic cardiologist linkurl:Steven Nissen.;http://my.clevelandclinic.org/staff_directory/2/staff_1185.aspx
**__Related stories:__***linkurl:New NIH head talks budget, priorities;http://www.the-scientist.com/blog/display/55179/
[10th November 2008]*linkurl:FDA's 1st Chief Scientist speaks;http://www.the-scientist.com/blog/display/54555/
[16th April 2008]*linkurl:Steve Nissen goes 0 for 2;http://www.the-scientist.com/blog/display/53284/
[14th June 2007]*linkurl:Accelerating new drug development;http://www.the-scientist.com/article/display/19429/
[30th January 2001]

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech